Reaction

Procoagulant Therapy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 749 reports · 2 co-occurring drugs

As of the last recalculation, Procoagulant Therapy appears in 749 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is DABIGATRAN ETEXILATE MESYLATE (PRR 17,539.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Dabigatran Etexilate Mesylate	737	17,539.0	17,719.9
Dabigatran Etexilate	721	6,875.8	6,940.6

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.